Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 44, Issue 8, 2016, Pages 807-816

  Peyrin Biroulet, L ^a   Germain, A ^a   Patel, A S ^b   Lindsay, J O ^c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Decision Resources Group   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANASTOMOSIS LEAKAGE; COLON RESECTION; COMORBIDITY; FECES INCONTINENCE; FISTULA; HARTMANN PROCEDURE; HUMAN; ILEAL POUCH ANAL ANASTOMOSIS; ILEITIS; ILEOANAL ANASTOMOSIS; ILEORECTAL ANASTOMOSIS; ILEUM POUCH; ILEUS; INCIDENCE; INFECTIOUS COMPLICATION; PELVIC DISEASE; PELVIC SEPSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROCTOCOLECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SMALL INTESTINE OBSTRUCTION; SURGICAL MORTALITY; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

EID: 84987792323     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13763     Document Type: Review

References (62)

1. Ford AC, Moayyedi P, Hanauer SB. Ulcerative colitis. BMJ 2013; 346: f432.
2. Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: current management. J Crohns Colitis 2012; 6: 991–1030.
3. NICE. Ulcerative colitis. Management in adults, children and young people, June 2013. Available at: http://www.nice.org.uk/nicemedia/live/14189/64216/64216.pdf (accessed 8 April 2014).
4. Nicholls RJ. Review article: ulcerative colitis–surgical indications and treatment. Aliment Pharmacol Ther 2002; 16(Suppl. 4): 25–8.
5. Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011; 141: 1194–201.
6. Magro F, Rodrigues A, Vieira AI, et al. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm Bowel Dis 2012; 18: 573–83.
7. Williet N, Pillot C, Oussalah A, et al. Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics. Inflamm Bowel Dis 2012; 18: 1641–6.
8. McLaughlin SD, Clark SK, Tekkis PP, Ciclitira PJ, Nicholls RJ. Review article: restorative proctocolectomy, indications, management of complications and follow-up–a guide for gastroenterologists. Aliment Pharmacol Ther 2008; 27: 895–909.
9. Cooke DM. Inflammatory bowel disease: primary health care management of ulcerative colitis and Crohn's disease. Nurse Pract 1991; 16: 27–30, 35–6, 38–9.
10. Fiocchi C. Towards a ‘cure’ for IBD. Dig Dis 2012; 30: 428–33.
11. Smith LE. A review of twenty-one rectal mucosectomy and ileal pouch pull through procedures. Am Surg 1986; 52: 182–7.
12. Sica GS, Biancone L. Surgery for inflammatory bowel disease in the era of laparoscopy. World J Gastroenterol 2013; 19: 2445–8.
13. Macdermott RP, Green JA. Refractory ulcerative colitis treatment. Gastroenterol Hepatol 2007; 3: 64–9.
14. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995; 222: 120–7.
15. Dayan B, Turner D. Role of surgery in severe ulcerative colitis in the era of medical rescue therapy. World J Gastroenterol 2012; 18: 3833–8.
16. Loftus EV, Leonard P, Yang M, Hayes O, Mulani P, Chao J. A retrospective study of colectomy complications and their associated costs for patients with ulcerative colitis. Gastroenterology 2012; 1: S198.
17. Lindsay JO, Bergman A, Patel AS, Alesso SM, Peyrin-Biroulet L. Systematic review: the financial burden of surgical complications in patients with ulcerative colitis. Aliment Pharmacol Ther 2015; 41: 1066–78.
18. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
19. NICE Guidelines Manual 2009 criteria. Appendix D Methodology checklist - randomised controlled trials. Available at: http://www.nice.org.uk/media/633/21/The_guidelines_manual_2009_-_Appendix_D_Methodology_checklist_-_randomised_controlled_trials.pdf (accessed 8 April 2014).
20. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377–84.
21. Frolkis A, Kaplan GG, Patel AB, et al. Postoperative complications and emergent readmission in children and adults with inflammatory bowel disease who undergo intestinal resection: a population-based study. Inflamm Bowel Dis 2014; 20: 1316–23.
22. Bikhchandani J, Polites SF, Wagie AE, Habermann EB, Cima RR. National trends of 3- versus 2-stage restorative proctocolectomy for chronic ulcerative colitis. Dis Colon Rectum 2015; 58: 199–204.
23. Robinson KA, O'Donnell ME, Pearson D, et al. Portomesenteric venous thrombosis following major colon and rectal surgery: incidence and risk factors. Surg Endosc 2015; 29: 1071–9.
24. Tyler AD, Milgrom R, Stempak JM, et al. The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis. Gut 2013; 62: 1433–9.
25. Coukos JA, Howard LA, Weinberg JM, Becker JM, Stucchi AF, Farraye FA. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis. Dig Dis Sci 2012; 57: 1544–53.
26. Gonzalez R, Pereyra L, Omodeo M, et al. Risk factors for complications after laparoscopic ileal-pouch-anal anastomosis in patients with ulcerative colitis. Abstact P360, European Crohn's and Colitis Organisation (ECCO). Poster presentantions: Clinical: Therapy & Observation 2014.
27. Bregnbak D, Mortensen C, Bendtsen F. Infliximab and complications after colectomy in patients with ulcerative colitis. J Crohns Colitis 2012; 6: 281–6.
28. Causey MW, Stoddard D, Johnson EK, et al. Laparoscopy impacts outcomes favorably following colectomy for ulcerative colitis: a critical analysis of the ACS-NSQIP database. Surg Endosc 2013; 27: 603–9.
29. Coakley BA, Divino CM. Identifying factors predictive of surgical-site infec-tions after colectomy for fulminant ulcerative colitis. Am Surg 2012; 78: 481–4.
30. Gainsbury ML, Chu DI, Howard LA, et al. Preoperative treatment with infliximab is not associated with an increased risk of short-term postoperative complications after colectomy with ileal pouch-anal anastomosis. Gastroenterology 2010; 1: S867.
31. Moore L, Tang L, Lopez R, Shen B. Clinical features of ileal pouch-anal anastomosis in African American patients with underlying ulcerative colitis. Aliment Pharmacol Ther 2009; 30: 385–91.
32. Nelson R, Liao C, Fichera A, Rubin DT, Pekow J. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis 2014; 20: 14–20.
33. Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204: 956–62.
34. Telem DA, Vine AJ, Swain G, et al. Laparoscopic subtotal colectomy for medically refractory ulcerative colitis: the time has come. Surg Endosc 2010; 24: 1616–20.
35. Uchino M, Ikeuchi H, Matsuoka H, et al. Infliximab administration prior to surgery does not increase surgical site infections in patients with ulcerative colitis. Int J Colorectal Dis 2013; 28: 1295–306.
36. Uchino M, Ikeuchi H, Matsuoka H, Tsuchida T, Tomita N, Takesue Y. Risk factors associated with surgical site infection after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum 2010; 53: 143–9.
37. Coakley BA, Telem D, Nguyen S, Dallas K, Divino CM. Prolonged preoperative hospitalization correlates with worse outcomes after colectomy for acute fulminant ulcerative colitis. Surgery 2013; 153: 242–8.
38. Dolejs S, Kennedy G, Heise CP. Small bowel obstruction following restorative proctocolectomy: affected by a laparoscopic approach? J Surg Res 2011; 170: 202–8.
39. Fichera A, Silvestri MT, Hurst RD, Rubin MA, Michelassi F. Laparoscopic restorative proctocolectomy with ileal pouch anal anastomosis: a comparative observational study on long-term functional results. J Gastrointest Surg 2009; 13: 526–32.
40. Loftus EV Jr, Delgado DJ, Friedman HS, Sandborn WJ. Colectomy and the incidence of postsurgical complications among ulcerative colitis patients with private health insurance in the United States. Am J Gastroenterol 2008; 103: 1737–45.
41. Pandey S, Luther G, Umanskiy K, et al. Minimally invasive pouch surgery for ulcerative colitis: is there a benefit in staging? Dis Colon Rectum 2011; 54: 306–10.
42. Wallaert JB, De Martino RR, Marsicovetere PS, et al. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum 2012; 55: 1138–44.
43. Itabashi M, Ikeuchi H, Araki T, et al. Effectiveness of leukocytapheresis in suppressing the occurrence of surgical site infections following surgery for ulcerative colitis. Surg Today 2008; 38: 609–17.
44. Oshima T, Takesue Y, Ikeuchi H, et al. Preoperative oral antibiotics and intravenous antimicrobial prophylaxis reduce the incidence of surgical site infections in patients with ulcerative colitis undergoing IPAA. Dis Colon Rectum 2013; 56: 1149–55.
45. Norgard BM, Nielsen J, Qvist N, Gradel KO, de Muckadell OBS, Kjeldsen J. Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study. Aliment Pharmacol Ther 2012; 35: 1301–9.
46. Colombo F, Sampietro G, Alice F, et al. Feasibility and safety of totally laparoscopic restorative proctocolectomy for ulcerative colitis in the elderly. A prospective cohort study. Abstract P502, European Crohn's and Colitis Organisation (ECCO). Poster presentations: Clinical: Therapy and Observation 2013.
47. Eshuis EJ, Al Saady RL, Stokkers PCF, Ponsioen CY, Tanis PJ, Bemelman WA. Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis. J Crohns Colitis 2013; 7: 142–9.
48. Ferrante M, D'Hoore A, Vermeire S, et al. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1062–70.
49. McLaughlin SD, Clark SK, Bell AJ, Tekkis PP, Ciclitira PJ, Nicholls RJ. Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2009; 52: 879–83.
50. Gainsbury ML, Chu DI, Howard LA, et al. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis. J Gastrointest Surg 2011; 15: 397–403.
51. Ananthakrishnan AN, Gainer VS, Cai T, et al. Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am J Gastroenterol 2013; 108: 594–601.
52. Bewtra M, Newcomb C, Wu Q, Lewis JD. Immunosuppressant therapy prior to elective surgery is not associated with increased post-operative morbidity in ulcerative colitis. Gastroenterology 2013; 1: S188.
53. Holubar SD, Larson DW, Dozois EJ, Pattana-arun J, Pemberton JH, Cima RR. Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach? Dis Colon Rectum 2009; 52: 187–92.
54. Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004; 47: 1119–26.
55. Loftus EV Jr, Friedman HS, Delgado DJ, Sandborn WJ. Colectomy subtypes, follow-up surgical procedures, postsurgical complications, and medical charges among ulcerative colitis patients with private health insurance in the United States. Inflamm Bowel Dis 2009; 15: 566–75.
56. Nasseri Y, Melmed G, Wang HL, Targan S, Fleshner P. Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis. Am J Gastroenterol 2010; 105: 155–61.
57. Okon A, Dubinsky M, Vasiliauskas EA, et al. Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis. Am Surg 2005; 71: 821–6.
58. Hueting WE, Buskens E, van der Tweel I, Gooszen HG, van Laarhoven CJHM. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg 2005; 22: 69–79.
59. Kuisma J, Jarvinen H, Kahri A, Farkkila M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004; 39: 544–8.
60. Leonard P, Yang M, Chao J, Mulani P. Complications associated with colectomy in patients with ulcerative colitis. Abstract P285, European Crohn's and Colitis Organisation (ECCO). Poster presentations: Clinical and Observation 2012.
61. Billioud V, Ford AC, Tedesco ED, Colombel JF, Roblin X, Peyrin-Biroulet L. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. J Crohns Colitis 2013; 7: 853–67.
62. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187–96.